Welcome to our dedicated page for Harte Hanks news (Ticker: HHS), a resource for investors and traders seeking the latest updates and insights on Harte Hanks stock.
Harte Hanks, Inc. (NASDAQ:HHS) is a global customer experience and data-driven marketing company whose news flow centers on financial performance, strategic partnerships, technology initiatives and transformation progress. The company regularly issues earnings releases detailing results for its Customer Care, Fulfillment & Logistics and Marketing Services segments, along with commentary on cost structure, EBITDA trends and balance sheet strength.
Investors following HHS news will see quarterly and full-year results, updates on its multi-year transformation program Project Elevate, and disclosures about leadership changes such as the appointment of a new President to oversee business segments and M&A initiatives. Harte Hanks also reports on material financing developments, including amendments to its asset-based revolving credit facility with Texas Capital Bank that extend maturities and add borrowing flexibility.
Operational and commercial updates are another key theme. Recent announcements include the opening of a dedicated Customer Care center in Greenville, South Carolina in partnership with Samsung Electronics America, and exclusive rights to license ADS Data Direct’s Medical Ailment Database to support compliant, high-precision healthcare marketing. The company also highlights collaborations with technology providers, such as its work with Reddy to apply AI-driven coaching and training within global contact center operations.
This news page aggregates these earnings releases, 8-K-linked announcements and corporate updates so readers can track how Harte Hanks executes its customer experience strategy, manages its capital resources and expands relationships with major brands across healthcare, technology, consumer, financial services and other sectors.
Harte Hanks (HHS) reported a 12% increase in Q1 revenues, reaching $49.0 million compared to $43.8 million in Q1 2021. The company achieved a net income of $3.3 million, reversing a net loss of $1.8 million from the prior year. Operating income improved to $3.9 million, up from an operating loss of $0.9 million. Growth was seen across all segments, particularly in Fulfillment & Logistics services, which saw a 28% increase. The company anticipates a $7.6 million NOL tax refund in 2022, supporting their liquidity.
Harte Hanks (Nasdaq: HHS) will release its financial results for Q1 2022 on May 12, 2022, following market close. A conference call is scheduled for the same day at 4:30 p.m. ET to discuss the results. The event will be accessible via webcast and telephone for interested parties. The company specializes in customer experience solutions, providing analytics and insights to help clients engage better with customers. Harte Hanks has a solid client base, including major brands such as Ford and Pfizer.
Harte Hanks (Nasdaq: HHS) has secured a contract with a multinational technology firm to enhance its B2B marketing through an omnichannel program. This agreement will leverage Harte Hanks' extensive experience in managing partner reseller initiatives, program strategy, media buying, and data analytics. CEO Brian Linscott emphasizes the focus on investing in technology and talent to foster growth for clients while optimizing their resources. The company boasts a long-term track record in delivering customer experience solutions across global markets.
Harte Hanks (Nasdaq: HHS) has announced its participation in the Noble Capital Markets' 18th Annual Investor Conference (NobleCon18) scheduled for April 20, 2022. The presentation will occur at 9:30 a.m. ET, at the Hard Rock Hotel & Casino in Hollywood, Florida. CEO Brian Linscott and CFO Lauri Kearnes will lead the discussion, with breakout sessions at 1:45 p.m. ET and 3:15 p.m. ET. Interested participants can register via Noble Capital Markets' website. A video webcast will be available the following day on Harte Hanks' investor relations site.
Harte Hanks (Nasdaq: HHS) partnered with a leading global financial services corporation to deliver over 300,000 at-home Covid-19 testing kits during the Omicron surge. Additionally, the company distributed more than 60,000 wellness kits containing hand sanitizers and PPE masks to its employees. This initiative was supported by their FDA-certified distribution center in Kansas City, allowing prompt delivery. The company emphasizes its significant investments in fulfillment facilities as a driver of growth amidst ongoing supply chain challenges.
Harte Hanks (HHS) reported a 10% revenue increase in Q4 2021, totaling $52.0 million, up from $47.1 million in Q4 2020. Diluted EPS rose to $0.20 from $0.11. Full-year revenues also improved by 10% to $194.6 million, while net income surged to $15.0 million compared to a net loss of $1.7 million in 2020. The company achieved an operating income of $7.6 million, reversing a previous loss. Cash and equivalents decreased to $15.1 million, but the company expects a $7.8 million tax refund to boost liquidity. CEO Brian Linscott emphasized sustainable profitability growth in 2022.
Harte Hanks, Inc. (Nasdaq: HHS) announced it will release its financial results for Q4 ended December 31, 2021, after the market closes on February 24, 2022. A conference call will follow at 4:30 p.m. ET to discuss the results. Interested parties can access the webcast online or via phone. The company specializes in customer experience strategies and analytics, serving clients like Bank of America and Pfizer, with over 2,500 employees in multiple regions.
Harte Hanks (Nasdaq: HHS) has secured a multi-year contract from a national healthcare organization to provide new mothers with essential products, including breast milk pumps and health-related materials. This initiative aligns with the Affordable Care Act's goal to enhance newborn nutrition. Over 100,000 breast milk kits are expected to be delivered in the first year. Harte Hanks was chosen for its comprehensive, cost-effective solutions and established relationship with the client, enabling efficient service delivery.
Harte Hanks (Nasdaq: HHS) announced the launch of an expanded healthcare practice, spearheaded by Janel Harris, an executive with extensive healthcare agency experience. The practice aims to leverage integrated services including patient insights and data analytics, enhancing client engagement in the healthcare sector. The company operates multiple distribution centers, including a new 400,000 square foot facility in Kansas City, fulfilling over 1.3 million packages annually. Harte Hanks continues to cater to major clients like GSK and Pfizer, aiming to provide comprehensive patient-centric solutions.
Harte Hanks (Nasdaq: HHS), a global customer experience company, will present at the Sidoti & Company Virtual Small-Cap Conference on January 20, 2022, at 10 a.m. ET. Management will also hold one-on-one meetings on January 19 and 20, 2022. Interested parties can access the presentation via webcast on the Harte Hanks investor relations website. For meeting requests, participants may contact their Sidoti representative or email hhs@fnkir.com.
FAQ
What is the current stock price of Harte Hanks (HHS)?
What is the market cap of Harte Hanks (HHS)?
